BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 6759026)

  • 21. Low risk of pelvic inflammatory disease in young never-pregnant women using Gravigard.
    Larsson B; Hagström B; Viberg L; Anker C; Hamberger L; Lindhe BA
    Contraception; 1979 Sep; 20(3):291-5. PubMed ID: 509955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of copper T-200 with Lippes loop as a contraceptive device.
    Wright EA; Aisien OA
    Int J Gynaecol Obstet; 1989 Jun; 29(2):173-7. PubMed ID: 2568294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [IUD and nulliparae (author's transl)].
    Nahmanovici C; Gelas M
    Contracept Fertil Sex (Paris); 1980 Jan; 8(1):19-27. PubMed ID: 12336141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathology of intra-uterine contraceptive devices.
    Buckley CH
    Curr Top Pathol; 1994; 86():307-30. PubMed ID: 8162713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pelvic inflammatory disease and the intrauterine contraceptive device.
    Wright EA; Aisien AO
    Int J Gynaecol Obstet; 1989 Feb; 28(2):133-6. PubMed ID: 2563699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of intrauterine devices. II. Intrauterine devices and pelvic inflammatory disease and ectopic pregnancy.
    Malhotra N; Chaudhury RR
    Obstet Gynecol Surv; 1982 Jan; 37(1):1-8. PubMed ID: 7054735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrauterine devices: present and future.
    Guillebaud J
    Int J Gynaecol Obstet; 1980; 18(5):325-32. PubMed ID: 6110576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescent experience with intrauterine device insertion and use: a retrospective cohort study.
    Bayer LL; Jensen JT; Li H; Nichols MD; Bednarek PH
    Contraception; 2012 Nov; 86(5):443-51. PubMed ID: 22560185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intrauterine device in the present and future.
    Rivera R; Chi IC; Farr G
    Curr Opin Obstet Gynecol; 1993 Dec; 5(6):829-32. PubMed ID: 8286697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of IUDs in developing countries: a comparative study.
    Farr G; Burdan A
    Netw Res Triangle Park N C; 1991 Sep; 12(2):6-8, 12. PubMed ID: 12284280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with the copper 7 intrauterine device in an adolescent population.
    Kulig JW; Rauh JL; Burket RL; Cabot HM; Brookman RR
    J Pediatr; 1980 Apr; 96(4):746-50. PubMed ID: 7359288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of the copper T intrauterine contraceptive device (TCu 200) in nulliparous women.
    Mishell DR; Israel R; Freid N
    Am J Obstet Gynecol; 1973 Aug; 116(8):1092-6. PubMed ID: 4721138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of the intrauterine device in nulliparous and parous women.
    Veldhuis HM; Vos AG; Lagro-Janssen AL
    Eur J Gen Pract; 2004 Sep; 10(3):82-7. PubMed ID: 15534571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Side effects and complications of intrauterine devices with special reference to pelvic infection].
    Marchino GL; Grio R; Garyphallides N; Zaccheo F; Carbone G
    Minerva Ginecol; 1986 Nov; 38(11):953-7. PubMed ID: 3808430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A statistical study of the copper T and copper 7 intrauterine devices.
    Gupta HD; Gupta I; Devi PK
    Contraception; 1976 Dec; 14(6):655-60. PubMed ID: 1017199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Copper T 220C: a new long-acting copper intrauterine contraceptive device.
    Cooper DL; Millen AK; Mishell DR
    Am J Obstet Gynecol; 1976 Jan; 124(2):121-4. PubMed ID: 1247047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.